Revance Therapeutics, Inc.
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect

Last updated:

Abstract:

A method of treating anxiety disorder comprising the steps of: identifying a subject with one or more symptoms of an anxiety disorder; a botulinum toxin to soft tissues outside the neurocranium using an injection selected from the grouop consisting of: transdermal injection; a subcutaneous injection; and a percutaneous injection; and thereby reducing at least one symptom of anxiety disorder.

Status:
Application
Type:

Utility

Filling date:

28 Dec 2020

Issue date:

19 Aug 2021